These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 15889976)
1. N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure. O'Donoghue M; Januzzi JL Expert Rev Cardiovasc Ther; 2005 May; 3(3):487-96. PubMed ID: 15889976 [TBL] [Abstract][Full Text] [Related]
2. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure. Morello AM; Januzzi JL Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901 [TBL] [Abstract][Full Text] [Related]
3. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670 [TBL] [Abstract][Full Text] [Related]
4. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Felker GM; Hasselblad V; Hernandez AF; O'Connor CM Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866 [TBL] [Abstract][Full Text] [Related]
5. BNP in the diagnosis and risk stratification of heart failure. Moe GW Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898 [TBL] [Abstract][Full Text] [Related]
6. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Januzzi JL; Chen-Tournoux AA; Moe G Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855 [TBL] [Abstract][Full Text] [Related]
9. Plasma NT-proBNP: a new biomarker for diagnosis and monitoring of congestive heart failure (CHF). Bayes-Genis A Timely Top Med Cardiovasc Dis; 2006 Apr; 10():E10. PubMed ID: 17066132 [No Abstract] [Full Text] [Related]
10. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
11. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921 [TBL] [Abstract][Full Text] [Related]
12. The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use. Januzzi JL Arch Cardiovasc Dis; 2012 Jan; 105(1):40-50. PubMed ID: 22369917 [TBL] [Abstract][Full Text] [Related]
13. Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment. Bruch C; Rothenburger M; Gotzmann M; Sindermann J; Scheld HH; Breithardt G; Wichter T J Am Soc Echocardiogr; 2006 May; 19(5):522-8. PubMed ID: 16644435 [TBL] [Abstract][Full Text] [Related]
14. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea. van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498 [TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome. Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of N-terminal proB-type natriuretic peptide. Costello-Boerrigter LC; Burnett JC Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):194-201. PubMed ID: 16265483 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema. Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317 [TBL] [Abstract][Full Text] [Related]
18. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Bettencourt P; Januzzi JL Am J Cardiol; 2008 Feb; 101(3A):67-71. PubMed ID: 18243862 [TBL] [Abstract][Full Text] [Related]
19. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting. Green SM; Green JA; Januzzi JL Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043 [TBL] [Abstract][Full Text] [Related]
20. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]